Aveanna Healthcare Holdings (AVAH) Cost of Revenue (2020 - 2026)

Aveanna Healthcare Holdings (AVAH) has 7 years of Cost of Revenue data on file, last reported at $449.2 million in Q1 2026.

• Quarterly Cost of Revenue rose 29.02% year-over-year to $449.2 million in Q1 2026, while the trailing twelve-month figure through Jan 2026 was $1.6 billion (up 16.83% YoY) and the FY2026 annual result came in at $1.6 billion, up 16.83% from the prior year.
• Cost of Revenue grew to $449.2 million in Q1 2026, from $419.1 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $449.2 million in Q1 2026 to a low of $297.9 million in Q3 2022.
• A 5-year average of $349.3 million and a median of $344.8 million in 2024 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2022 — Cost of Revenue decreased 17.7% — and 2026, when it increased 29.02%.
• Tracing AVAH's Cost of Revenue over 5 years: stood at $322.4 million in 2022, then gained by 2.49% to $330.4 million in 2023, then grew by 5.37% to $348.2 million in 2024, then advanced by 20.38% to $419.1 million in 2025, then advanced by 7.17% to $449.2 million in 2026.
• The last three Cost of Revenue figures came in at $449.2 million (Q1 2026), $419.1 million (Q3 2025), and $378.8 million (Q2 2025), per Business Quant data.